すべての臨床医が知っておきたい腸内細菌叢

出版社： 羊土社
著者：
発行日： 2021-04-10
分野： 臨床医学：内科  >  消化器一般
ISBN： 9784758123693
電子書籍版： 2021-04-10 （第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

4,730 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,730 円(税込)

購入する

商品紹介

飛躍的に進展する腸内細菌研究について，本当に知りたいエビデンスとポイントを解説！「疾患との関わりでわかっていることは？」「プロバイオティクスはどれがよい？」腸内細菌叢に興味があり，気軽に学びたい方に！

目次

  • 腸内細菌の分類表

    第1章　腸内細菌叢の基本を理解しよう
    　1　腸内細菌叢は遺伝子情報で解析できる
    　2　日本人腸内細菌叢の特徴は？
    　3　母子環境が決める腸内細菌叢
    　4　幼少時ストレスによるディスバイオーシス
    　5　高脂肪食が変える腸内細菌叢
    　6　食物繊維と腸内細菌叢
    　7　ディスバイオーシスと腸管粘液層
    　8　腸内細菌叢に影響する環境要因
    　9　腸内細菌叢に影響する宿主遺伝子
    　10　腸内細菌叢解析からその代謝物解析に

    第2章　腸内細菌叢と疾患研究でわかっていること，いないこと
    　1　炎症性疾患・免疫関連疾患
    　2　代謝性疾患
    　3　がん・腫瘍免疫
    　4　脳腸相関と精神・神経系疾患
    　5　腎・心・血管系疾患
    　6　機能性消化管障害
    　7　産婦人科疾患
    　8　スポーツ・疲労・不眠

    第3章　腸内細菌叢を標的にした治療にはどんなものがあるか
    　1　医薬品としてのプロバイオティクス
    　2　診療ガイドライン・メタ解析からみたプロバイオティクスの位置づけ
    　3　乳酸菌とその機能性
    　4　ビフィズス菌とその機能性
    　5　酪酸菌とその機能性
    　6　機能性表示食品の新展開
    　7　次世代善玉菌
    　8　糞便微生物移植療法の新展開
    　9　高発酵性食物繊維による腸内環境改善策
    　10　ファージセラピーの臨床

おすすめ商品

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 腸内細菌叢の基本を理解しよう

P.29 掲載の参考文献
1) Kawada Y, et al : Effect of storage and DNA extraction method on 16S rRNA-profiled fecal microbiota in Japanese adults. J Clin Biochem Nutr, 64 : 106-111, 2019
 
2) Nishijima S, et al : The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res, 23 : 125-133, 2016
 
3) Yachida S, et al : Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med, 25 : 968-976, 2019
 
4) Arumugam M, et al : Enterotypes of the human gut microbiome. Nature, 473 : 174-180, 2011
 
5) Wu GD, et al : Linking long-term dietary patterns with gut microbial enterotypes. Science, 334 : 105-108, 2011
 
6) Nakayama J, et al : Diversity in gut bacterial community of school-age children in Asia. Sci Rep, 5 : 8397, 2015
 
7) Vandeputte D, et al : Quantitative microbiome profiling links gut community variation to microbial load. Nature, 551 : 507-511, 2017
 
8) Tierney BT, et al : The predictive power of the microbiome exceeds that of genome-wide association studies in the discrimination of complex human disease. bioRχiv, 2019. https://doi.org/10.1101/2019.12.31.891978
 
9) Kashiwagi S, et al : Mucosa-Associated Microbiota in the Gastrointestinal Tract of Healthy Japanese Subjects. Digestion, 101 : 107-120, 2020
 
10) Nishino K, et al : Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease. J Gastroenterol, 53 : 95-106, 2018
 
11) Fukui A, et al : Higher Levels of Streptococcus in Upper Gastrointestinal Mucosa Associated with Symptoms in Patients with Functional Dyspepsia. Digestion, 101 : 38-45, 2020
PubMed
12) Matsumoto H, et al : Analysis of the colonic mucosa associated microbiota (MAM) using brushing samples during colonic endoscopic procedures. J Clin Biochem Nutr, 65 : 132-137, 2019
PubMed
13) Sundin J, et al : Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome. Sci Rep, 10 : 593, 2020
PubMed
14) Chen XH, et al : Mucosa-Associated Microbiota in Gastric Cancer Tissues Compared With Non-cancer Tissues. Front Microbiol, 10 : 1261, 2019
PubMed
15) Richard ML, et al : Mucosa-associated microbiota dysbiosis in colitis associated cancer. Gut Microbes, 9 : 131-142, 2018
PubMed
P.37 掲載の参考文献
1) Nishijima S, et al : The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res, 23 : 125-133, 2016
 
2) He Y, et al : Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nat Med, 24 : 1532-1535, 2018
PubMed
3) Deschasaux M, et al : Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat Med, 24 : 1526-1531, 2018
 
4) Takagi T, et al : Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. J Gastroenterol, 54 : 53-63, 2019
PubMed
5) Gao X, et al : Body Mass Index Differences in the Gut Microbiota Are Gender Specific. Front Microbiol, 9 : 1250, 2018
PubMed
6) Wang JJ, et al : Sex differences in colonization of gut microbiota from a man with short-term vegetarian and inulin-supplemented diet in germ-free mice. Sci Rep, 6 : 36137, 2016
PubMed
7) Cross TL, et al : Sexual dimorphism of cardiometabolic dysfunction : Gut microbiome in the play? Mol Metab, 15 : 70-81, 2018
PubMed
8) Harada N, et al : Hypogonadism alters cecal and fecal microbiota in male mice. Gut Microbes, 7 : 533-539, 2016
PubMed
9) Harada N : Role of androgens in energy metabolism affecting on body composition, metabolic syndrome, type 2 diabetes, cardiovascular disease, and longevity : lessons from a meta-analysis and rodent studies. Biosci Biotechnol Biochem, 82 : 1667-1682, 2018
PubMed
10) Harada N, et al : Role of gut microbiota in sex- and diet-dependent metabolic disorders that lead to early mortality of androgen receptor-deficient male mice. Am J Physiol Endocrinol Metab, 318 : E525-E537, 2020
PubMed
11) Poutahidis T, et al : Probiotic microbes sustain youthful serum testosterone levels and testicular size in aging mice. PLoS One, 9 : e84877, 2014
PubMed
12) Hamajima H, et al : Japanese traditional dietary fungus koji Aspergillus oryzae functions as a prebiotic for Blautia coccoides through glycosylceramide : Japanese dietary fungus koji is a new prebiotic. Springerplus, 5 : 1321, 2016
PubMed
P.48 掲載の参考文献
1) Diaz Heijtz R : Fetal, neonatal, and infant microbiome : Perturbations and subsequent effects on brain development and behavior. Semin Fetal Neonatal Med, 21 : 410-417, 2016
PubMed
2) Chu DM, et al : The early infant gut microbiome varies in association with a maternal high-fat diet. Genome Med, 8 : 77, 2016
PubMed
3) Buffington SA, et al : Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell, 165 : 1762-1775, 2016
PubMed
4) Kimura I, et al : Maternal gut microbiota in pregnancy influences offspring metabolic phenotype in mice. Science, 367 : eaaw 8429, 2020
 
5) Neu J : The microbiome during pregnancy and early postnatal life. Semin Fetal Neonatal Med, 21 : 373-379, 2016
PubMed
6) Aagaard K, et al : Una destinatio, viae diversae : Does exposure to the vaginal microbiota confer health benefits to the infant, and does lack of exposure confer disease risk? EMBO Rep, 17 : 1679-1684, 2016
 
7) Urushiyama D, et al : Microbiome profile of the amniotic fluid as a predictive biomarker of perinatal outcome. Sci Rep, 7 : 12171, 2017
PubMed
8) Younge N, et al : Fetal exposure to the maternal microbiota in humans and mice. JCI Insight, 4 : doi : 10.1172/jci.insight.127806, 2019
 
9) Rackaityte E, et al : Viable bacterial colonization is highly limited in the human intestine in utero. Nat Med, 26 : 599-607, 2020
PubMed
10) 光岡知足 : 腸内細菌叢研究の歴史. 実験医学増刊, 32 : 652-657, 2014
 
11) Shao Y, et al : Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature, 574 : 117-121, 2019
PubMed
12) Makino H, et al : Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant's microbiota. PLoS One, 8 : e78331, 2013
PubMed
13) Dominguez-Bello MG, et al : Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med, 22 : 250-253, 2016
PubMed
14) Korpela K, et al : Maternal fecal microbiota transplantation in cesarean-born infants rapidly restores normal gut microbial development : a proof-of-concept study. Cell 183 : 324-334, 2020
PubMed
15) Stewart CJ, et al : Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature, 562 : 583-588, 2018
PubMed
16) Yatsunenko T, et al : Human gut microbiome viewed across age and geography. Nature, 486 : 222-227, 2012
PubMed
17) Rekima A, et al : A role for early oral exposure to house dust mite allergens through breast milk in IgE-mediated food allergy susceptibility. J Allergy Clin Immunol, 145 : 1416-1429.e11, 2020
 
P.55 掲載の参考文献
1) Korpela K, et al : Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun, 7 : 10410, 2016
PubMed
2) Schulfer AF, et al : Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. Nat Microbiol, 3 : 234-242, 2018
PubMed
3) Tochitani S, et al : Administration of non-absorbable antibiotics to pregnant mice to perturb the maternal gut microbiota is associated with alterations in offspring behavior. PLoS One, 11 : e0138293, 2016
PubMed
4) Murakami T, et al : Changes in intestinal motility and gut microbiota composition in a rat stress model. Digestion, 95 : 55-60, 2017
 
5) Zhong XS, et al : Neonatal colonic inflammation epigenetically aggravates epithelial inflammatory responses to injury in adult life. Cell Mol Gastroenterol Hepatol, 6 : 65-78, 2018
PubMed
6) Fukui H, et al : Effect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats. Sci Rep, 8 : 12384, 2018
PubMed
7) Flannery JE, et al : Gut feelings begin in childhood : the gut metagenome correlates with early environment, caregiving, and behavior. mBio, 11 : e02780-19, 2020
PubMed
8) Harusato A, et al : Early-life microbiota exposure restricts myeloid-derived suppressor cell-driven colonic tumorigenesis. Cancer Immunol Res, 7 : 544-551, 2019
PubMed
P.64 掲載の参考文献
1) Carmody RN, et al : Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe, 17 : 72-84, 2015
PubMed
2) Bruce-Keller AJ, et al : Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity. Biol Psychiatry, 77 : 607-615, 2015
PubMed
3) Wan Y, et al : Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors : a 6-month randomised controlled-feeding trial. Gut, 68 : 1417-1429, 2019
PubMed
4) Martinez-Guryn K, et al : Small intestine microbiota regulate host digestive and absorptive adaptive responses to dietary lipids. Cell Host Microbe, 23 : 458-469.e5, 2018
 
5) Ushiroda C, et al : Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice. J Clin Biochem Nutr, 65 : 34-46, 2019
PubMed
6) Murakami M, et al : Detection of gut dysbiosis due to reduced Clostridium subcluster XIVa using the fecal or serum bile acid profile. Inflamm Bowel Dis, 24 : 1035-1044, 2018
PubMed
7) Honda A, et al : Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. J Lipid Res, 61 : 54-69, 2020
PubMed
8) Kohsaka A, et al : High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab, 6 : 414-421, 2007
PubMed
9) Hatori M, et al : Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab, 15 : 848-860, 2012
PubMed
10) Kuang Z, et al : The intestinal microbiota programs diurnal rhythms in host metabolism through histone deacetylase 3. Science, 365 : 1428-1434, 2019
PubMed
11) Zarrinpar A, et al : Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab, 20 : 1006-1017, 2014
PubMed
P.75 掲載の参考文献
1) Reynolds A, et al : Carbohydrate quality and human health : a series of systematic reviews and meta-analyses. Lancet, 393 : 434-445, 2019
 
2) Katagiri R, et al : Dietary fiber intake and total and cause-specific mortality : the Japan Public Health Center-based prospective study. Am J Clin Nutr, 111 : 1027-1035, 2020
PubMed
3) David LA, et al : Diet rapidly and reproducibly alters the human gut microbiome. Nature, 505 : 559-563, 2014
PubMed
4) David LA, et al : Host lifestyle affects human microbiota on daily timescales. Genome Biol, 15 : R89, 2014
PubMed
5) Zhao L, et al : Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science, 359 : 1151-1156, 2018
PubMed
6) Sonnenburg ED, et al : Diet-induced extinctions in the gut microbiota compound over generations. Nature, 529 : 212-215, 2016
PubMed
7) Desai MS, et al : A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell, 167 : 1339-1353.e21, 2016
 
8) Trompette A, et al : Dietary fiber confers protection against Flu by shaping Ly6c- patrolling monocyte hematopoiesis and CD8+ T cell metabolism. Immunity, 48 : 992-1005.e8, 2018
 
9) Song M, et al : Fiber intake and survival after colorectal cancer diagnosis. JAMA Oncol, 4 : 71-79, 2018
PubMed
P.82 掲載の参考文献
1) Johansson ME, et al : The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci U S A, 108 Suppl 1 : 4659-4665, 2011
 
2) Desai MS, et al : A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell, 167 : 1339-1353.e21, 2016
 
3) Van der Sluis M, et al : Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology, 131 : 117-129, 2006
PubMed
4) Liso M, et al : A specific mutation in Muc2 determines early dysbiosis in colitis-prone Winnie mice. Inflamm Bowel Dis, 26 : 546-556, 2020
PubMed
5) Chassaing B, et al : Colonic microbiota encroachment correlates with dysglycemia in humans. Cell Mol Gastroenterol Hepatol, 4 : 205-221, 2017
PubMed
6) Chassaing B, et al : Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature, 519 : 92-96, 2015
PubMed
7) Chassaing B, et al : Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut, 66 : 1414-1427, 2017
PubMed
8) Sugahara H, et al : Decreased taxon-specific IgA response in relation to the changes of gut microbiota composition in the elderly. Front Microbiol, 8 : 1757, 2017
 
9) Okai S, et al : High-affinity monoclonal IgA regulates gut microbiota and prevents colitis in mice. Nat Microbiol, 1 : 16103, 2016
 
10) Okai S, et al : Intestinal IgA as a modulator of the gut microbiota. Gut Microbes, 8 : 486-492, 2017
PubMed
11) Masuda K, et al : Bactericidal activity of mouse α-defensin cryptdin-4 predominantly affects noncommensal bacteria. J Innate Immun, 3 : 315-326, 2011
 
12) Shimizu Y, et al : Paneth cell α-defensin misfolding correlates with dysbiosis and ileitis in Crohn's disease model mice. Life Sci Alliance, 3 : e201900592, 2020
 
P.93 掲載の参考文献
1) Dong TS & Gupta A : Influence of early life, diet, and the environment on the microbiome. Clin Gastroenterol Hepatol, 17 : 231-242, 2019
PubMed
2) De Filippo C, et al : Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A, 107 : 14691-14696, 2010
PubMed
3) Park SH, et al : Comparative analysis of gut microbiota in elderly people of urbanized towns and longevity villages. BMC Microbiol, 15 : 49, 2015
PubMed
4) Scott FI, et al : Administration of antibiotics to children before age 2 years increases risk for childhood obesity. Gastroenterology, 151 : 120-129.e5, 2016
 
5) Stark CM, et al : Antibiotic and acid-suppression medications during early childhood are associated with obesity. Gut, 68 : 62-69, 2019
PubMed
6) Zhang J, et al : Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012 : a matched case-control study. Gut, 68 : 1971-1978, 2019
PubMed
7) 「失われていく, 我々の内なる細菌」 (マーティン・J・ブレイザー/著, 山本太郎/訳), pp1-286, みすず書房, 2015
 
8) Otsuka T, et al : Influence of potassium-competitive acid blocker on the gut microbiome of Helicobacter pylori-negative healthy individuals. Gut, 66 : 1723-1725, 2017
PubMed
9) Takagi T, et al : The influence of long-term use of proton pump inhibitors on the gut microbiota : an age-sex-matched case-control study. J Clin Biochem Nutr, 62 : 100-105, 2018
PubMed
10) Naito Y, et al : Intestinal dysbiosis secondary to proton-pump inhibitor use. Digestion, 97 : 195-204, 2018
PubMed
11) Jordakieva G, et al : Country-wide medical records infer increased allergy risk of gastric acid inhibition. Nat Commun, 10 : 3298, 2019
PubMed
12) Willems RPJ, et al : Evaluation of the association between gastric acid suppression and risk of intestinal colonization with multidrug-resistant microorganisms : a systematic review and meta-analysis. JAMA Intern Med, 180 : 561-571, 2020
PubMed
13) Ruiz PA, et al : Titanium dioxide nanoparticles exacerbate DSS-induced colitis : role of the NLRP3 inflammasome. Gut, 66 : 1216-1224, 2017
PubMed
14) Urrutia-Ortega IM, et al : Food-grade titanium dioxide exposure exacerbates tumor formation in colitis associated cancer model. Food Chem Toxicol, 93 : 20-31, 2016
PubMed
15) Pinget G, et al : Impact of the food additive titanium dioxide (E171) on gut microbiota-host interaction. Front Nutr, 6 : 57, 2019
PubMed
16) Suez J, et al : Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature, 514 : 181-186, 2014
PubMed
17) Ruiz-Ojeda FJ, et al : Effects of sweeteners on the gut microbiota : a review of experimental studies and clinical Trials. Adv Nutr, 10 : S31-S48, 2019
PubMed
P.101 掲載の参考文献
1) Goodrich JK, et al : Human genetics shape the gut microbiome. Cell, 159 : 789-799, 2014
PubMed
2) Matsuki T, et al : A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat Commun, 7 : 11939, 2016
PubMed
3) Yamada C, et al : Molecular insight into evolution of symbiosis between breast-fed infants and a member of the human gut microbiome Bifidobacterium longum. Cell Chem Biol, 24 : 515-524.e5, 2017
 
4) Shigeno Y, et al : Gut microbiota development in mice is affected by hydrogen peroxide produced from amino acid metabolism during lactation. FASEB J, 33 : 3343-3352, 2019
PubMed
5) Blekhman R, et al : Host genetic variation impacts microbiome composition across human body sites. Genome Biol, 16 : 191, 2015
PubMed
6) Kato K, et al : Association between functional lactase variants and a high abundance of Bifidobacterium in the gut of healthy Japanese people. PLoS One, 13 : e0206189, 2018
 
7) Shimizu Y, et al : Paneth cell α-defensin misfolding correlates with dysbiosis and ileitis in Crohn's disease model mice. Life Sci Alliance, 3 : e201900592, 2020
 
8) Wu S, et al : Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut, 64 : 1082-1094, 2015
PubMed
9) Wu S, et al : Vitamin D receptor pathway is required for probiotic protection in colitis. Am J Physiol Gastrointest Liver Physiol, 309 : G341-G349, 2015
PubMed
10) Wang J, et al : Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nat Genet, 48 : 1396-1406, 2016
PubMed
11) Ishida S, et al : Genome-wide association studies and heritability analysis reveal the involvement of host genetics in the Japanese gut microbiota. Commun Biol, 3 : 686, 2020
PubMed
P.122 掲載の参考文献
1) Takagi T, et al : Partially hydrolysed guar gum ameliorates murine intestinal inflammation in association with modulating luminal microbiota and SCFA. Br J Nutr, 116 : 1199-1205, 2016
PubMed
2) Nishijima S, et al : The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res, 23 : 125-133, 2016
 
3) Fukuda S, et al : Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature, 469 : 543-547, 2011
PubMed
4) Nakano T, et al : Promotion of wound healing by acetate in murine colonic epithelial cell via c-Jun N-terminal kinase activation. J Gastroenterol Hepatol, 35 : 1171-1179, 2020
 
5) Frost G, et al : The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun, 5 : 3611, 2014
 
6) Chambers ES, et al : Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut, 64 : 1744-1754, 2015
 
7) Higashimura Y, et al : Propionate Promotes Fatty Acid Oxidation through the Up-Regulation of Peroxisome Proliferator-Activated Receptor α in Intestinal Epithelial Cells. J Nutr Sci Vitaminol (Tokyo), 61 : 511-515, 2015
 
8) Inoue D, et al : Short-chain fatty acid receptor GPR41-mediated activation of sympathetic neurons involves synapsin 2b phosphorylation. FEBS Lett, 586 : 1547-1554, 2012
PubMed
9) Kimura I, et al : Maternal gut microbiota in pregnancy influences offspring metabolic phenotype in mice. Science, 367 : eaaw8429, 2020
PubMed
10) Tirosh A, et al : The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans. Sci Transl Med, 11 : eaav0120, 2019
PubMed
11) Litvak Y, et al : Colonocyte metabolism shapes the gut microbiota. Science, 362 : 6418, 2018
PubMed
12) Furusawa Y, et al : Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature, 504 : 446-450, 2013
PubMed
13) Atarashi K, et al : Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science, 358 : 359-365, 2017
PubMed
14) Ji J, et al : Microbial metabolite butyrate facilitates M2 macrophage polarization and function. Sci Rep, 6 : 24838, 2016
PubMed
15) Sanchez HN, et al : B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids. Nat Commun, 11 : 60, 2020
PubMed
16) Kobayashi R, et al : Comparison of the fecal microbiota of two monogastric herbivorous and five omnivorous mammals. Anim Sci J, 91 : e13366, 2020
PubMed
17) Sanna S, et al : Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet, 51 : 600-605, 2019
PubMed
18) Morita N, et al : GPR31-dependent dendrite protrusion of intestinal CX3CR1+ cells by bacterial metabolites. Nature, 566 : 110-114, 2019
PubMed
19) Saji N, et al : Analysis of the relationship between the gut microbiome and dementia : a cross-sectional study conducted in Japan. Sci Rep, 9 : 1008, 2019
PubMed
20) Saji N, et al : Relationship between dementia and gut microbiome-associated metabolites : a cross-sectional study in Japan. Sci Rep, 10 : 8088, 2020
PubMed
21) De Vadder F, et al : Microbiota-Produced Succinate Improves Glucose Homeostasis via Intestinal Gluconeogenesis. Cell Metab, 24 : 151-157, 2016
PubMed
22) Takagi T, et al : Partially hydrolysed guar gum ameliorates murine intestinal inflammation in association with modulating luminal microbiota and SCFA. Br J Nutr, 116 : 1199-1205, 2016
PubMed
23) de Vadder F & Mithieux G : Gut-brain signaling in energy homeostasis : the unexpected role of microbiota-derived succinate. J Endocrinol, 236 : R105-R108, 2018
PubMed
24) He W, et al : Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature, 429 : 188-193, 2004
PubMed
25) Kishino S, et al : Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition. Proc Natl Acad Sci U S A, 110 : 17808-17813, 2013
PubMed
26) Miyamoto J, et al : A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway. J Biol Chem, 290 : 2902-2918, 2015
PubMed
27) Miyamoto J, et al : Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids. Nat Commun, 10 : 4007, 2019
PubMed
28) Madeo F, et al : Spermidine in health and disease. Science, 359 : doi : 10.1126/science. aan2788, 2018
 
29) Matsumoto M, et al : Longevity in mice is promoted by probiotic-induced suppression of colonic senescence dependent on upregulation of gut bacterial polyamine production. PLoS One, 6 : e23652, 2011
 
30) Matsumoto M, et al : Impact of intestinal microbiota on intestinal luminal metabolome. Sci Rep, 2 : 233, 2012
PubMed
31) Wang Z, et al : Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 472 : 57-63, 2011
PubMed
32) Tang WH, et al : Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure : refining the gut hypothesis. J Am Coll Cardiol, 64 : 1908-1914, 2014
PubMed
33) Cohen LJ, et al : Commensal bacteria make GPCR ligands that mimic human signalling molecules. Nature, 549 : 48-53, 2017
PubMed
34) 池上正, 他 : 腸内フローラによる胆汁酸の代謝. 肝胆膵, 577 : 57-64, 2018
 
35) Fu J & Kuipers F : Systems genetics approach reveals cross-talk between bile acids and intestinal microbes. PLoS Genet, 15 : e1008307, 2019
PubMed
36) Humbert L, et al : Bile acid profiling in human biological samples : comparison of extraction procedures and application to normal and cholestatic patients. J Chromatogr B Analyt Technol Biomed Life Sci, 899 : 135-145, 2012
PubMed
37) Brial F, et al : The Natural Metabolite 4-Cresol Improves Glucose Homeostasis and Enhances β-Cell Function. Cell Rep, 30 : 2306-2320.e5, 2020
 
38) Roager HM & Licht TR : Microbial tryptophan catabolites in health and disease. Nat Commun, 9 : 3294, 2018
PubMed
39) Lee JH & Lee J : Indole as an intercellular signal in microbial communities. FEMS Microbiol Rev, 34 : 426-444, 2010
PubMed
40) Cussotto S, et al : Tryptophan Metabolic Pathways Are Altered in Obesity and Are Associated With Systemic Inflammation. Front Immunol, 11 : 557, 2020
PubMed
41) Singh R, et al : Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat Commun, 10 : 89, 2019
PubMed
42) Sasabe J, et al : Interplay between microbial d-amino acids and host d-amino acid oxidase modifies murine mucosal defence and gut microbiota. Nat Microbiol, 1 : 16125, 2016
 
43) Matsumoto M, et al : Free D-amino acids produced by commensal bacteria in the colonic lumen. Sci Rep, 8 : 17915, 2018
 

第2章 腸内細菌叢と疾患研究でわかっていること, いないこと

P.144 掲載の参考文献
1) Andoh A, et al : Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol, 46 : 479-486, 2011
PubMed
2) Kashiwagi S, et al : Mucosa-Associated Microbiota in the Gastrointestinal Tract of Healthy Japanese Subjects. Digestion, 101 : 107-120, 2020
 
3) Nishino K, et al : Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease. J Gastroenterol, 53 : 95-106, 2018
 
4) Sokol H, et al : Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A, 105 : 16731-16736, 2008
PubMed
5) Takahashi K, et al : Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease. Digestion, 93 : 59-65, 2016
PubMed
6) Sasaki K, et al : Construction of a Model Culture System of Human Colonic Microbiota to Detect Decreased Lachnospiraceae Abundance and Butyrogenesis in the Feces of Ulcerative Colitis Patients. Biotechnol J, 14 : e1800555, 2019
 
7) Miyake S, et al : Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS One, 10 : e0137429, 2015
PubMed
8) Leylabadlo HE, et al : The critical role of Faecalibacterium prausnitzii in human health : An overview. Microb Pathog, 149 : 104344, 2020
PubMed
9) Henke MT, et al : Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide. Proc Natl Acad Sci U S A, 116 : 12672-12677, 2019
PubMed
10) Vieira-Silva S, et al : Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses. Nat Microbiol, 4 : 1826-1831, 2019
PubMed
11) Ohkusa T, et al : Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut, 52 : 79-83, 2003
PubMed
12) Ohkusa T, et al : Newly developed antibiotic combination therapy for ulcerative colitis : a double-blind placebo-controlled multicenter trial. Am J Gastroenterol, 105 : 1820-1829, 2010
PubMed
13) Uchiyama K, et al : Assessment of Endoscopic Mucosal Healing of Ulcerative Colitis Using Linked Colour Imaging, a Novel Endoscopic Enhancement System. J Crohns Colitis, 11 : 963-969, 2017
PubMed
14) Aden K, et al : Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases. Gastroenterology, 157 : 1279-1292.e11, 2019
 
15) Yoshimatsu Y, et al : Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis. World J Gastroenterol, 21 : 5985-5994, 2015
PubMed
16) Yasueda A, et al : The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis. Surg Today, 46 : 939-949, 2016
PubMed
17) Azad MB, et al : Infant gut microbiota and food sensitization : associations in the first year of life. Clin Exp Allergy, 45 : 632-643, 2015
PubMed
18) Abdel-Gadir A, et al : Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy. Nat Med, 25 : 1164-1174, 2019
 
19) Tan J, et al : Dietary Fiber and Bacterial SCFA Enhance Oral Tolerance and Protect against Food Allergy through Diverse Cellular Pathways. Cell Rep, 15 : 2809-2824, 2016
PubMed
20) Lee KH, et al : The gut microbiota, environmental factors, and links to the development of food allergy. Clin Mol Allergy, 18 : 5, 2020
 
21) Baiz N, et al : Early oral exposure to house dust mite allergen through breast milk : A potential risk factor for allergic sensitization and respiratory allergies in children. J Allergy Clin Immunol, 139 : 369-372.e10, 2017
 
22) Rekima A, et al : A role for early oral exposure to house dust mite allergens through breast milk in IgE-mediated food allergy susceptibility. J Allergy Clin Immunol, 145 : 1416-1429.e11, 2020
 
23) Chua HH, et al : Intestinal Dysbiosis Featuring Abundance of Ruminococcus gnavus Associates With Allergic Diseases in Infants. Gastroenterology, 154 : 154-167, 2018
PubMed
24) Galazzo G, et al : Development of the Microbiota and Associations With Birth Mode, Diet, and Atopic Disorders in a Longitudinal Analysis of Stool Samples, Collected From Infancy Through Early Childhood. Gastroenterology, 158 : 1584-1596, 2020
 
25) Scher JU, et al : Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife, 2 : e01202, 2013
PubMed
26) Zhang X, et al : The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med, 21 : 895-905, 2015
PubMed
27) Maeda Y, et al : Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine. Arthritis Rheumatol, 68 : 2646-2661, 2016
PubMed
28) Kishikawa T, et al : Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population. Ann Rheum Dis, 79 : 103-111, 2020
PubMed
29) Rosser EC, et al : Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells. Cell Metab, 31 : 837-851.e10, 2020
 
30) McDonald JAK, et al : Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota. Gastroenterology, 155 : 1495-1507.e15, 2018
 
31) Buffie CG, et al : Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature, 517 : 205-208, 2015
PubMed
32) Greathouse KL, et al : Dysfunctional families : Clostridium scindens and secondary bile acids inhibit the growth of Clostridium difficile. Cell Metab, 21 : 9-10, 2015
PubMed
33) Kang JD, et al : Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile : Role of Secondary Bile Acids. Cell Chem Biol, 26 : 27-34.e4, 2019
 
34) Mullish BH, et al : Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection. Gut, 68 : 1791-1800, 2019
PubMed
35) Nagao-Kitamoto H, et al : Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota. Nat Med, 26 : 608-617, 2020
PubMed
36) Hamming I, et al : Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol, 203 : 631-637, 2004
PubMed
37) Hashimoto T, et al : ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature, 487 : 477-481, 2012
PubMed
38) Yamamoto Y, et al : Effect of ingesting yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 on influenza virus-bound salivary IgA in elderly residents of nursing homes : a randomized controlled trial. Acta Odontol Scand, 77 : 517-524, 2019
PubMed
39) Haak BW, et al : Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood, 131 : 2978-2986, 2018
PubMed
40) Antunes KH, et al : Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat Commun, 10 : 3273, 2019
PubMed
41) He Y, et al : Gut-lung axis : The microbial contributions and clinical implications. Crit Rev Microbiol, 43 : 81-95, 2017
PubMed
42) Budden KF, et al : Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol, 15 : 55-63, 2017
PubMed
43) Li N, et al : The Commensal Microbiota and Viral Infection : A Comprehensive Review. Front Immunol, 10 : 1551, 2019
PubMed
44) Sze MA, et al : Changes in the bacterial microbiota in gut, blood, and lungs following acute LPS instillation into mice lungs. PLoS One, 9 : e111228, 2014
PubMed
45) Bai C, et al : Effect of High Calorie Diet on Intestinal Flora in LPS-Induced Pneumonia Rats. Sci Rep, 10 : 1701, 2020
PubMed
46) King S, et al : Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions : a systematic review and meta-analysis. Br J Nutr, 112 : 41-54, 2014
PubMed
47) Kalantar-Zadeh K, et al : Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection : Nanotechnology Roles. ACS Nano, 14 : 5179-5182, 2020
PubMed
P.162 掲載の参考文献
1) Qin J, et al : A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature, 490 : 55-60, 2012
 
2) Karlsson FH, et al : Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature, 498 : 99-103, 2013
PubMed
3) Hashimoto Y, et al : Intake of sucrose affects gut dysbiosis in patients with type 2 diabetes. J Diabetes Investig : doi : 10.1111/jdi.13293, 2020
 
4) Tilg H & Moschen AR : Microbiota and diabetes : an evolving relationship. Gut, 63 : 1513-1521, 2014
PubMed
5) Naito Y, et al : A next-generation beneficial microbe : Akkermansia muciniphila. J Clin Biochem Nutr, 63 : 33-35, 2018
PubMed
6) Sato J, et al : Gut dysbiosis and detection of" live gut bacteria" in blood of Japanese patients with type 2 diabetes. Diabetes Care, 37 : 2343-2350, 2014
PubMed
7) Wu H, et al : Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med, 23 : 850-858, 2017
 
8) Morita Y, et al : Enhanced Release of Glucose Into the Intraluminal Space of the Intestine Associated With Metformin Treatment as Revealed by [18F] Fluorodeoxyglucose PETMRI. Diabetes Care, 43 : 1796-1802, 2020
 
9) Brial F, et al : The Natural Metabolite 4-Cresol Improves Glucose Homeostasis and Enhances β-Cell Function. Cell Rep, 30 : 2306-2320.e5, 2020
 
10) Naito Y, et al : Identification of cysteinylated transthyretin, a predictive biomarker of treatment response to partially hydrolyzed guar gum in type 2 diabetes rats, by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. J Clin Biochem Nutr, 58 : 23-33, 2016
PubMed
11) Reynolds A, et al : Carbohydrate quality and human health : a series of systematic reviews and meta-analyses. Lancet, 393 : 434-445, 2019
 
12) Zhao L, et al : Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science, 359 : 1151-1156, 2018
PubMed
13) Turnbaugh PJ, et al : An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 444 : 1027-1031, 2006
PubMed
14) Ridaura VK, et al : Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341 : 1241214, 2013
PubMed
15) Goodrich JK, et al : Human genetics shape the gut microbiome. Cell, 159 : 789-799, 2014
PubMed
16) Zhang T, et al : Akkermansia muciniphila is a promising probiotic. Microb Biotechnol, 12 : 1109-1125, 2019
PubMed
17) Everard A, et al : Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A, 110 : 9066-9071, 2013
PubMed
18) Plovier H, et al : A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med, 23 : 107-113, 2017
PubMed
19) Dao MC, et al : Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity : relationship with gut microbiome richness and ecology. Gut 65 : 426-436, 2016
PubMed
20) Depommier C, et al : Supplementation with Akkermansia muciniphila in overweight and obese human volunteers : a proof-of-concept exploratory study. Nat Med, 25 : 1096-1103, 2019
PubMed
21) Takagi T, et al : Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. J Gastroenterol, 54 : 53-63, 2019
PubMed
22) Ozato N, et al : Blautia genus associated with visceral fat accumulation in adults 20-76 years of age. NPJ Biofilms Microbiomes, 5 : 28, 2019
PubMed
23) Nishijima S, et al : The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res, 23 : 125-133, 2016
 
24) Kurakawa T, et al : Diversity of Intestinal Clostridium coccoides Group in the Japanese Population, as Demonstrated by Reverse Transcription-Quantitative PCR. PLoS One, 10 : e0126226, 2015
PubMed
25) Vieira-Silva S, et al : Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature, 581 : 310-315, 2020
PubMed
26) Imajo K, et al : Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. Cell Metab, 16 : 44-54, 2012
PubMed
27) Ogawa Y, et al : Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis. PLoS One, 8 : e65211, 2013
PubMed
28) Tsai MC, et al : Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease : A Cross-Sectional Study in Taiwan. Nutrients, 12 : doi : 10.3390/nu12030820, 2020
 
29) Zhu L, et al : Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients : a connection between endogenous alcohol and NASH. Hepatology, 57 : 601-609, 2013
PubMed
30) Yuan J, et al : Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae. Cell Metab, 30 : 675-688.e7, 2019"
 
31) Nakamoto N, et al : Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat Microbiol, 4 : 492-503, 2019"
PubMed
32) Caussy C, et al : Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD. Aliment Pharmacol Ther, 49 : 183-193, 2019
PubMed
33) Kobyliak N, et al : A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients : Evidence from a Randomized Clinical Trial. J Gastrointestin Liver Dis, 27 : 41-49, 2018
PubMed
34) Duseja A, et al : High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD) : a randomised, double-blind, proof of concept study. BMJ Open Gastroenterol, 6 : e000315, 2019
PubMed
35) Ahn SB, et al : Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease. Sci Rep, 9 : 5688, 2019
PubMed
36) Scorletti E, et al : Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology, 158 : 1597-1610.e7, 2020
 
37) Sato K, et al : Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med, 203 : 2673-2682, 2006
 
38) Ivanov II, et al : Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell, 139 : 485-498, 2009
PubMed
39) Tyagi AM, et al : The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression. Immunity, 49 : 1116-1131.e7, 2018
 
P.185 掲載の参考文献
1) Tanda N, et al : Professional Oral Care Reduces Carcinogenic Acetaldehyde Levels in Mouth Air of Perioperative Esophageal Cancer Patients : A Prospective Comparative Study. Tohoku J Exp Med, 249 : 75-83, 2019
PubMed
2) Tagaino R, et al : Metabolic property of acetaldehyde production from ethanol and glucose by oral Streptococcus and Neisseria. Sci Rep, 9 : 10446, 2019
PubMed
3) Hiraki A, et al : Teeth loss and risk of cancer at 14 common sites in Japanese. Cancer Epidemiol Biomarkers Prev, 17 : 1222-1227, 2008
PubMed
4) Yamamura K, et al : Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis. Clin Cancer Res, 22 : 5574-5581, 2016
PubMed
5) Shao D, et al : Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China. Cancer, 125 : 3993-4002, 2019
PubMed
6) Snider EJ, et al : Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev, 28 : 1687-1693, 2019
 
7) Majima A, et al : Early-Stage Gastric Cancer Can Be Found in Improved Atrophic Mucosa over Time from Successful Helicobacter pylori Eradication. Digestion, 95 : 194-200, 2017
PubMed
8) Dohi O, et al : Can image-enhanced endoscopy improve the diagnosis of Kyoto classification of gastritis in the clinical setting? Dig Endosc, 32 : 191-203, 2020
 
9) Dohi O, et al : Linked color imaging improves endoscopic diagnosis of active Helicobacter pylori infection. Endosc Int Open, 4 : E800-E805, 2016
PubMed
10) Majima A, et al : Linked color imaging identifies important risk factors associated with gastric cancer after successful eradication of Helicobacter pylori. Gastrointest Endosc, 90 : 763-769, 2019
PubMed
11) Coker OO, et al : Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut, 67 : 1024-1032, 2018
PubMed
12) Sung JJY, et al : Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication. Gut : doi : 10.1136/gutjnl-2019-319826, 2020
 
13) 内藤裕二 : Helicobacter pyloriと腸内細菌の関連. 日本内科学会雑誌 110 : 64-69, 2021
 
14) Correa P : Human gastric carcinogenesis : a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res, 52 : 6735-6740, 1992
PubMed
15) Matsubara S, et al : Induction of glandular stomach cancers in Helicobacter pylori-infected Mongolian gerbils by 1-nitrosoindole-3-acetonitrile. Int J Cancer, 130 : 259-266, 2012
PubMed
16) Wilck N, et al : Salt-responsive gut commensal modulates TH17 axis and disease. Nature, 551 : 585-589, 2017
PubMed
17) Kostic AD, et al : Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res, 22 : 292-298, 2012
PubMed
18) Castellarin M, et al : Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res, 22 : 299-306, 2012
PubMed
19) Takagi T, et al : Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. J Gastroenterol, 54 : 53-63, 2019
PubMed
20) Ito M, et al : Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Int J Cancer, 137 : 1258-1268, 2015
PubMed
21) Mima K, et al : Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location. Clin Transl Gastroenterol, 7 : e200, 2016
PubMed
22) Komiya Y, et al : Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity. Gut, 68 : 1335-1337, 2019
PubMed
23) Yachida S, et al : Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med, 25 : 968-976, 2019
 
24) Erawijantari PP, et al : Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles. Gut, 69 : 1404-1415, 2020
PubMed
25) Nguyen LH, et al : Association Between Sulfur-Metabolizing Bacterial Communities in Stool and Risk of Distal Colorectal Cancer in Men. Gastroenterology, 158 : 1313-1325, 2020
PubMed
26) Song M, et al : Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. Gastroenterology, 158 : 322-340, 2020
PubMed
27) Yazici C, et al : Race-dependent association of sulfidogenic bacteria with colorectal cancer. Gut, 66 : 1983-1994, 2017
PubMed
28) Mehta RS, et al : Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue. JAMA Oncol, 3 : 921-927, 2017
PubMed
29) Fan Y, et al : Meta-analysis of the association between the inflammatory potential of diet and colorectal cancer risk. Oncotarget, 8 : 59592-59600, 2017
PubMed
30) Liu L, et al : Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum. Clin Gastroenterol Hepatol, 16 : 1622-1631.e3, 2018
 
31) Cho YA, et al : Inflammatory Dietary Pattern, IL-17F Genetic Variant, and the Risk of Colorectal Cancer. Nutrients, 10 : doi : 10.3390/nu10060724, 2018
 
32) Tabung FK, et al : Development and Validation of an Empirical Dietary Inflammatory Index. J Nutr, 146 : 1560-1570, 2016
PubMed
33) Tabung FK, et al : Association of Dietary Inflammatory Potential With Colorectal Cancer Risk in Men and Women. JAMA Oncol, 4 : 366-373, 2018
PubMed
34) Murakami M, et al : Detection of Gut Dysbiosis due to Reduced Clostridium Subcluster XIVa Using the Fecal or Serum Bile Acid Profile. Inflamm Bowel Dis, 24 : 1035-1044, 2018
PubMed
35) Kuhn T, et al : Prediagnostic Plasma Bile Acid Levels and Colon Cancer Risk : A Prospective Study. J Natl Cancer Inst, 112 : 516-524, 2020
 
36) Arthur JC, et al : Intestinal inflammation targets cancer-inducing activity of the microbiota. Science, 338 : 120-123, 2012
PubMed
37) Hirayama Y, et al : Activity-Based Probe for Screening of High-Colibactin Producers from Clinical Samples. Org Lett, 21 : 4490-4494, 2019
PubMed
38) Ponziani FR, et al : Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease. Hepatology, 69 : 107-120, 2019
PubMed
39) Yoshimoto S, et al : Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature, 499 : 97-101, 2013
PubMed
40) Kang JD, et al : Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile : Role of Secondary Bile Acids. Cell Chem Biol, 26 : 27-34.e4, 2019
 
41) Devendran S, et al : Clostridium scindens ATCC 35704 : Integration of Nutritional Requirements, the Complete Genome Sequence, and Global Transcriptional Responses to Bile Acids. Appl Environ Microbiol, 85 : doi : 10.1128/AEM.00052-19, 2019
 
42) Farrell JJ, et al : Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut, 61 : 582-588, 2012
PubMed
43) Ren Z, et al : Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China. Oncotarget, 8 : 95176-95191, 2017
PubMed
44) Riquelme E, et al : Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell, 178 : 795-806.e12, 2019
 
45) Aykut B, et al : The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature, 574 : 264-267, 2019
PubMed
46) Sivan A, et al : Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science, 350 : 1084-1089, 2015
PubMed
47) Vetizou M, et al : Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science, 350 : 1079-1084, 2015
PubMed
48) Tanoue T, et al : A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature, 565 : 600-605, 2019
PubMed
49) Routy B, et al : Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science, 359 : 91-97, 2018
PubMed
50) Gopalakrishnan V, et al : Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science, 359 : 97-103, 2018
PubMed
51) Dubin K, et al : Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat Commun, 7 : 10391, 2016
PubMed
52) Abu-Sbeih H, et al : Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis : a multi-center study. J Immunother Cancer, 6 : 142, 2018
PubMed
53) Wang Y, et al : Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat Med, 24 : 1804-1808, 2018
PubMed
P.205 掲載の参考文献
1) Sudo N, et al : Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol, 558 : 263-275, 2004
PubMed
2) Valles-Colomer M, et al : The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol, 4 : 623-632, 2019
PubMed
3) Aizawa E, et al : Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. J Affect Disord, 202 : 254-257, 2016
PubMed
4) Zheng P, et al : Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol Psychiatry, 21 : 786-796, 2016
 
5) Chen JJ, et al : Sex differences in gut microbiota in patients with major depressive disorder. Neuropsychiatr Dis Treat, 14 : 647-655, 2018
PubMed
6) Benton D, et al : Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr, 61 : 355-361, 2007
PubMed
7) Messaoudi M, et al : Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr, 105 : 755-764, 2011
PubMed
8) Akkasheh G, et al : Clinical and metabolic response to probiotic administration in patients with major depressive disorder : A randomized, double-blind, placebo-controlled trial. Nutrition, 32 : 315-320, 2016
PubMed
9) Kazemi A, et al : Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder : A randomized clinical trial. Clin Nutr, 38 : 522-528, 2019
PubMed
10) Takagi T, et al : Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. J Gastroenterol, 54 : 53-63, 2019
PubMed
11) Rampelli S, et al : Shotgun Metagenomics of Gut Microbiota in Humans with up to Extreme Longevity and the Increasing Role of Xenobiotic Degradation. mSystems, 5 : doi : 10.1128/mSystems.00124-20, 2020
 
12) Naito Y, et al : Gut microbiota differences in elderly subjects between rural city Kyotango and urban city Kyoto : an age-gender-matched study. J Clin Biochem Nutr, 65 : 125-131, 2019
 
13) Barcena C, et al : Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. Nat Med, 25 : 1234-1242, 2019
PubMed
14) Ushiroda C, et al : Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice. J Clin Biochem Nutr, 65 : 34-46, 2019
PubMed
15) 山村隆 : 腸内細菌と多発性硬化症. 日本内科学会誌, 105 : 1717-1721, 2016
 
16) Miyake S, et al : Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS One, 10 : e0137429, 2015
PubMed
17) Jangi S, et al : Alterations of the human gut microbiome in multiple sclerosis. Nat Commun, 7 : 12015, 2016
PubMed
18) Reynders T, et al : Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes. Ann Clin Transl Neurol, 7 : 406-419, 2020
PubMed
19) Kadowaki A, et al : Gut microbiota-dependent CCR9+ CD4+ T cells are altered in secondary progressive multiple sclerosis. Brain, 142 : 916-931, 2019
PubMed
20) Rothhammer V, et al : Microglial control of astrocytes in response to microbial metabolites. Nature, 557 : 724-728, 2018
PubMed
21) Rothhammer V, et al : Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med, 22 : 586-597, 2016
PubMed
22) Villumsen M, et al : Inflammatory bowel disease increases the risk of Parkinson's disease : a Danish nationwide cohort study 1977-2014. Gut, 68 : 18-24, 2019
PubMed
23) Maeda T, et al : Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson's disease patients from 35 medical centers. Parkinsonism Relat Disord, 38 : 54-60, 2017
PubMed
24) Gao X, et al : A prospective study of bowel movement frequency and risk of Parkinson's disease. Am J Epidemiol, 174 : 546-551, 2011
 
25) Hasegawa S, et al : Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease. PLoS One, 10 : e0142164, 2015
PubMed
26) Suzuki A, et al : Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease. PLoS One, 13 : e0208313, 2018
PubMed
27) Minato T, et al : Progression of Parkinson's disease is associated with gut dysbiosis : Twoyear follow-up study. PLoS One, 12 : e0187307, 2017
 
28) Bedarf JR, et al : Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients. Genome Med, 9 : 39, 2017
 
29) Maini Rekdal V, et al : Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science, 364 : doi : 10.1126/science.aau6323, 2019
 
30) Blacher E, et al : Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature, 572 : 474-480, 2019
PubMed
31) Flannery JE, et al : Gut Feelings Begin in Childhood : the Gut Metagenome Correlates with Early Environment, Caregiving, and Behavior. mBio, 11 : doi : 10.1128/mBio.02780-19, 2020
 
32) Kang DW, et al : Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota. Sci Rep, 9 : 5821, 2019
PubMed
33) Inoue R, et al : Dietary supplementation with partially hydrolyzed guar gum helps improve constipation and gut dysbiosis symptoms and behavioral irritability in children with autism spectrum disorder. J Clin Biochem Nutr, 64 : 217-223, 2019
PubMed
P.216 掲載の参考文献
1) Kikuchi K, et al : Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease. Nat Commun, 10 : 1835, 2019
PubMed
2) Sasabe J, et al : Interplay between microbial d-amino acids and host d-amino acid oxidase modifies murine mucosal defence and gut microbiota. Nat Microbiol, 1 : 16125, 2016
 
3) Castillo-Rodriguez E, et al : Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression. Toxins (Basel), 10 : doi : 10.3390/toxins10070300, 2018
 
4) Nakade Y, et al : Gut microbiota-derived D-serine protects against acute kidney injury. JCI Insight, 3 : doi : 10.1172/jci.insight.97957, 2018
 
5) Hesaka A, et al : D-Serine reflects kidney function and diseases. Sci Rep, 9 : 5104, 2019
PubMed
6) Lopes RCSO, et al : Modulation of intestinal microbiota, control of nitrogen products and inflammation by pre/probiotics in chronic kidney disease : a systematic review. Nutr Hosp, 35 : 722-730, 2018
PubMed
7) Arumugam M, et al : Enterotypes of the human gut microbiome. Nature, 473 : 174-180, 2011
 
8) Emoto T, et al : Analysis of Gut Microbiota in Coronary Artery Disease Patients : a Possible Link between Gut Microbiota and Coronary Artery Disease. J Atheroscler Thromb, 23 : 908-921, 2016
PubMed
9) Emoto T, et al : Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism : gut microbiota could be a diagnostic marker of coronary artery disease. Heart Vessels, 32 : 39-46, 2017
PubMed
10) Yoshida N, et al : Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis. Circulation 138 : 2486-2498, 2018
PubMed
11) Yoshida N, et al : Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease. J Atheroscler Thromb, 26 : 705-719, 2019
PubMed
12) Wang Z, et al : Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 472 : 57-63, 2011
PubMed
13) Tang WH, et al : Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med, 368 : 1575-1584, 2013
PubMed
14) Wang Z, et al : Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell, 163 : 1585-1595, 2015
PubMed
15) Roberts AB, et al : Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat Med, 24 : 1407-1417, 2018
PubMed
16) Tripolt NJ, et al : Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome : An open-label, randomized study. Atherosclerosis, 242 : 141-144, 2015
PubMed
17) Matsumoto M, et al : Bifidobacterium animalis subsp. lactis LKM512 reduces levels of intestinal trimethylamine produced by intestinal microbiota in healthy volunteers : A double-blind, placebo-controlled study. Journal of Functional Foods, 36 : 94-101, 2017
 
18) Matsumoto M, et al : Endothelial Function is improved by Inducing Microbial Polyamine Production in the Gut : A Randomized Placebo-Controlled Trial. Nutrients, 11 : doi : 10.3390/nu11051188, 2019
 
19) Tonomura S, et al : Intracerebral hemorrhage and deep microbleeds associated with cnm-positive Streptococcus mutans ; a hospital cohort study. Sci Rep, 6 : 20074, 2016
PubMed
20) Matsuura J, et al : Analysis of gut microbiota in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). J Clin Biochem Nutr, 65 : 240-244, 2019
PubMed
21) Wilck N, et al : Salt-responsive gut commensal modulates TH17 axis and disease. Nature, 551 : 585-589, 2017
PubMed
22) Chen L, et al : Modest Sodium Reduction Increases Circulating Short-Chain Fatty Acids in Untreated Hypertensives : A Randomized, Double-Blind, Placebo-Controlled Trial. Hypertension, 76 : 73-79, 2020
PubMed
P.233 掲載の参考文献
1) Vanheel H, et al : Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut, 63 : 262-271, 2014
PubMed
2) Enck P, et al : Functional dyspepsia. Nat Rev Dis Primers, 3 : 17081, 2017
PubMed
3) Fukui A, et al : Higher Levels of Streptococcus in Upper Gastrointestinal Mucosa Associated with Symptoms in Patients with Functional Dyspepsia. Digestion, 101 : 38-45, 2020
PubMed
4) Moser AM, et al : Effects of an oral synbiotic on the gastrointestinal immune system and microbiota in patients with diarrhea-predominant irritable bowel syndrome. Eur J Nutr, 58 : 2767-2778, 2019
PubMed
5) Shanahan ER, et al : Influence of cigarette smoking on the human duodenal mucosa-associated microbiota. Microbiome, 6 : 150, 2018
PubMed
6) Tian H, et al : Fecal microbiota transplantation in patients with slow-transit constipation : A randomized, clinical trial. PLoS One, 12 : e0171308, 2017
PubMed
7) Pimentel M, et al : Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med, 364 : 22-32, 2011
PubMed
8) Mearin F, et al : Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak : one-year follow-up cohort study. Gastroenterology, 129 : 98-104, 2005
PubMed
9) Zanini B, et al : Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. Am J Gastroenterol, 107 : 891-899, 2012
PubMed
10) Spiller R & Garsed K : Postinfectious irritable bowel syndrome. Gastroenterology, 136 : 1979-1988, 2009
PubMed
11) Pittayanon R, et al : Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review. Gastroenterology, 157 : 97-108, 2019
PubMed
12) Wang L, et al : Gut Microbial Dysbiosis in the Irritable Bowel Syndrome : A Systematic Review and Meta-Analysis of Case-Control Studies. J Acad Nutr Diet, 120 : 565-586, 2020
PubMed
13) Tana C, et al : Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil, 22 : 512-9, e114, 2010
 
14) Pozuelo M, et al : Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci Rep, 5 : 12693, 2015
PubMed
15) Rangel I, et al : The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects. Aliment Pharmacol Ther, 42 : 1211-1221, 2015
PubMed
16) Sundin J, et al : Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects. Sci Rep, 8 : 16821, 2018
 
17) Sundin J, et al : Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome. Sci Rep, 10 : 593, 2020
PubMed
18) Mackes NK, et al : Early childhood deprivation is associated with alterations in adult brain structure despite subsequent environmental enrichment. Proc Natl Acad Sci U S A, 117 : 641-649, 2020
PubMed
19) Heaton KW, et al : Defecation frequency and timing, and stool form in the general population : a prospective study. Gut, 33 : 818-824, 1992
PubMed
20) Degen LP & Phillips SF : How well does stool form reflect colonic transit? Gut, 39 : 109-113, 1996
PubMed
21) Longstreth GF, et al : Functional bowel disorders. Gastroenterology, 130 : 1480-1491, 2006
PubMed
22) Ohkubo H, et al : Relationship between Stool Form and Quality of Life in Patients with Chronic Constipation : An Internet Questionnaire Survey. Digestion : 1-8, 2019
PubMed
23) Muller T, et al : Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C. Gut, 65 : 1306-1313, 2016
PubMed
24) Vandeputte D, et al : Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut, 65 : 57-62, 2016
PubMed
25) Takagi T, et al : Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. J Gastroenterol, 54 : 53-63, 2019
PubMed
26) Parthasarathy G, et al : Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. Gastroenterology, 150 : 367-79.e1, 2016
 
27) Keely S, et al : Activated fluid transport regulates bacterial-epithelial interactions and significantly shifts the murine colonic microbiome. Gut Microbes, 3 : 250-260, 2012
PubMed
28) Kato T, et al : Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut : A prospective randomized pilot study in healthy volunteers. PLoS One, 12 : e0175626, 2017
 
29) Tronstad RR, et al : Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease. Inflamm Bowel Dis, 23 : 1752-1761, 2017
 
30) Ge X, et al : Potential role of fecal microbiota from patients with slow transit constipation in the regulation of gastrointestinal motility. Sci Rep, 7 : 441, 2017
PubMed
31) Inoue R, et al : Dietary supplementation with partially hydrolyzed guar gum helps improve constipation and gut dysbiosis symptoms and behavioral irritability in children with autism spectrum disorder. J Clin Biochem Nutr, 64 : 217-223, 2019
PubMed
32) Vieira-Silva S, et al : Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature, 581 : 310-315, 2020
PubMed
33) Vandeputte D, et al : Quantitative microbiome profiling links gut community variation to microbial load. Nature, 551 : 507-511, 2017
 
34) Fiskerstrand T, et al : Familial diarrhea syndrome caused by an activating GUCY2C mutation. N Engl J Med, 366 : 1586-1595, 2012
PubMed
35) Romi H, et al : Meconium ileus caused by mutations in GUCY2C, encoding the CFTR-activating guanylate cyclase 2C. Am J Hum Genet, 90 : 893-899, 2012
PubMed
P.239 掲載の参考文献
1) Komiya S, et al : Characterrizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary intervention study. J Clin Biochem Nutr 67 : 105-111, 2020
PubMed
2) Qi X, et al : Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med, 25 : 1225-1233, 2019
PubMed
3) Akiyama K, et al : Molecular detection of microbial colonization in cervical mucus of women with and without endometriosis. Am J Reprod Immunol, 82 : e13147, 2019
PubMed
4) Leonardi M, et al : Endometriosis and the microbiome : a systematic review. BJOG, 127 : 239-249, 2020
PubMed
5) Cohen CR, et al : Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis. N Engl J Med, 382 : 1906-1915, 2020
PubMed
P.247 掲載の参考文献
1) Barton W, et al : The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut, 67 : 625-633, 2018
PubMed
2) Scheiman J, et al : Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat Med, 25 : 1104-1109, 2019
PubMed
3) Aoi W, et al : A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut, 62 : 882-889, 2013
 
4) Hughes RL : A Review of the Role of the Gut Microbiome in Personalized Sports Nutrition. Front Nutr, 6 : 191, 2019
PubMed
5) Moreno-Perez D, et al : Effect of a Protein Supplement on the Gut Microbiota of Endurance Athletes : A Randomized, Controlled, Double-Blind Pilot Study. Nutrients, 10 : doi : 10.3390/nu10030337, 2018
 
6) Giloteaux L, et al : Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome, 4 : 30, 2016
PubMed
7) Wang T, et al : Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function. PLoS One, 13 : e0203503, 2018
PubMed
8) Mandarano AH, et al : Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome. PeerJ, 6 : e4282, 2018
PubMed
9) Du Preez S, et al : A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis. Syst Rev, 7 : 241, 2018
PubMed
10) Thaiss CA, et al : Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell, 159 : 514-529, 2014
PubMed
11) Leone V, et al : Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism. Cell Host Microbe, 17 : 681-689, 2015
PubMed

第3章 腸内細菌叢を標的にした治療にはどんなものがあるか

P.258 掲載の参考文献
1) Seki H, et al : Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI. Pediatr Int, 45 : 86-90, 2003
PubMed
2) Yasueda A, et al : The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis. Surg Today, 46 : 939-949, 2016
PubMed
3) Shimbo I, et al : Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy. World J Gastroenterol, 11 : 7520-7524, 2005
 
4) Isa K, et al : Safety assessment of the Clostridium butyricum MIYAIRI 588(R) probiotic strain including evaluation of antimicrobial sensitivity and presence of Clostridium toxin genes in vitro and teratogenicity in vivo. Hum Exp Toxicol, 35 : 818-832, 2016
PubMed
5) Yoshimatsu Y, et al : Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis. World J Gastroenterol, 21 : 5985-5994, 2015
PubMed
6) Song EJ, et al : Effect of probiotics on obesity-related markers per enterotype : a double-blind, placebo-controlled, randomized clinical trial. EPMA J, 11 : 31-51, 2020
PubMed
P.263 掲載の参考文献
1) 「慢性便秘症診療ガイドライン 2017」 (日本消化器病学会関連研究会 慢性便秘の診断・治療研究会/編), 南江堂, 2017
 
2) 「機能性消化管疾患診療ガイドライン 2020 改訂第2版 過敏性腸症候群 (IBS) 」 (日本消化器病学会/編), 南江堂, 2020
 
3) Ford AC, et al : Systematic review with meta-analysis : the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther, 48 : 1044-1060, 2018
PubMed
4) 日本化学療法学会・日本感染症学会 : Clostridioides (Clostridium) difficile感染症診療ガイドライン. 日本化学療法学会雑誌, 66 : 645-690, 2018 http://www.chemotherapy.or.jp/guideline/cdi_shinryou.pdf
 
5) Goldenberg JZ, et al : Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev, 12 : CD006095, 2017
 
6) 「H. pylori感染の診断と治療のガイドライン 2016 改訂版」 (日本ヘリコバクター学会ガイドライン作成委員会/編), 先端医学社, 2016
 
7) 「小児期ヘリコバクター・ピロリ感染症の診療と管理ガイドライン 2018 (改訂2版) 」 (日本小児栄養消化器肝臓学会/編), 2018 http://www.jspghan.org/images/helicobacter_guideline2018.pdf
 
8) Yu M, et al : Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication : A meta-analysis of randomized controlled trials. PLoS One, 14 : e0223309, 2019
PubMed
9) Shimbo I, et al : Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy. World J Gastroenterol, 11 : 7520-7524, 2005
 
10) Mukai R, et al : Effectiveness of including probiotics to Helicobacter pylori eradication therapies. J Clin Biochem Nutr, 67 : 102-104, 2020
PubMed
11) 「炎症性腸疾患 (IBD) 診療ガイドライン 2020」 (日本消化器病学会/編), 南江堂, 2020
 
12) 第I部 小児急性胃腸炎診療ガイドライン「エビデンスに基づいた子どもの腹部救急診療ガイドライン 2017」 (日本小児救急医学会診療ガイドライン作成委員会/編), 2017
 
13) 「JAID/JSC感染症治療ガイド 2019」 (JAID/JSC感染症治療ガイド・ガイドライン作成委員会/編), ライフサイエンス出版, 2019
 
14) 2014 Guidelines for the Management of Acute Gastroenteritis in children in Europe https://www.espghan.org/knowledge-center/publications/Gastroenterology/2014_Guidelines_for_the_Management_of_Acute_Gastroenteritis_in_children_in_Europe
 
15) Schnadower D, et al : Lactobacillus rhamnosus GG versusplacebo for acute gastroenteritis in children. N Engl J Med, 379 : 2002-2014, 2018
 
16) Freedman SB, et al : Multicenter trial of a combination probiotic for children with gastroenteritis. N Engl J Med, 379 : 2015-2026, 2018
PubMed
17) Martinelli M, et al : Probiotics' efficacy in paediatric diseases : which is the evidence? A critical review on behalf of the Italian Society of Pediatrics. Ital J Pediatr, 46 : 104, 2020
 
18) 「静脈経腸栄養ガイドライン 第3版」 (日本静脈経腸栄養学会/編), 照林社, 2013
 
19) Braga TD, et al : Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants : a double-blind, randomized, controlled trial. Am J Clin Nutr, 93 : 81-86, 2011
PubMed
20) Neu J & Walker WA : Necrotizing enterocolitis. N Engl J Med, 364 : 255-264, 2011
PubMed
21) 日本感染症学会 : 気道感染症の抗菌薬使用に関する提言 https://www.kansensho.or.jp/uploads/files/guidelines/093050623_teigen.pdf
 
22) 日本皮膚科学会, 他 : アトピー性皮膚炎診療ガイドライン 2018. 日皮会誌, 128 : 2431-2502, 2018 https://www.dermatol.or.jp/uploads/uploads/files/guideline/atopic_GL2018.pdf
 
23) Panduru M, et al : Probiotics and primary prevention of atopic dermatitis : a meta-analysis of randomized controlled studies. J Eur Acad Dermatol Venereol, 29 : 232-242, 2015
PubMed
24) Kim SO, et al : Effects of probiotics for the treatment of atopic dermatitis : a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol, 113 : 217-226, 2014
PubMed
P.277 掲載の参考文献
1) Sato J, et al : Probiotic reduces bacterial translocation in type 2 diabetes mellitus : A randomised controlled study. Sci Rep, 7 : 12115, 2017
PubMed
2) Qi X, et al : The probiotic Lactobacillus casei Shirota attenuates symptoms of vestibular migraine : a randomised placebo-controlled double-blind clinical trial. Benef Microbes, 11 : 469-476, 2020
 
3) Macnaughtan J, et al : A Double-Blind, Randomized Placebo-Controlled Trial of Probiotic Lactobacillus casei Shirota in Stable Cirrhotic Patients. Nutrients, 12 : doi : 10.3390/nu12061651, 2020
 
4) Kushiro A, et al : Decreased number of days of fever detection and duration of fever with continuous intake of a fermented milk drink : a randomized, double-blind, placebo-controlled study of elderly nursing home residents. Biosci Microbiota Food Health, 38 : 151-157, 2019
PubMed
5) Li B, et al : Probiotic Lactobacillus casei Shirota improves efficacy of amoxicillin-sulbactam against childhood fast breathing pneumonia in a randomized placebo-controlled double blind clinical study. J Clin Biochem Nutr, 63 : 233-237, 2018
 
6) Naito E, et al : Effect of Lactobacillus casei strain Shirota-fermented milk on metabolic abnormalities in obese prediabetic Japanese men : a randomised, double-blind, placebo-controlled trial. Biosci Microbiota Food Health, 37 : 9-18, 2018
 
7) Guo C, et al : Oral Administration of Probiotic Lactobacillus Casei Shirota Decreases Pneumonia and Increases Pulmonary Functions after Single Rib Fracture : A Randomized Double-Blind, Placebo-Controlled Clinical Trial. J Food Sci, 83 : 2222-2226, 2018
PubMed
8) Makino S, et al : Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Br J Nutr, 104 : 998-1006, 2010
PubMed
9) Yamamoto Y, et al : Effect of ingesting yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 on influenza virus-bound salivary IgA in elderly residents of nursing homes : a randomized controlled trial. Acta Odontol Scand, 77 : 517-524, 2019
PubMed
10) Makino S, et al : Anti-Fatigue Effects of Yogurt Fermented with Lactobacillus delbureckii subsp. bulgaricus OLL1073R-1 in Healthy People Suffering from Summer Heat Fatigue : A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 10 : doi : 10.3390/nu10070798, 2018
 
11) Takagi A, et al : Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori-Associated Dyspepsia : A Multicenter Randomized Double-Blind Controlled Trial. Gastroenterol Res Pract, 2016 : 7490452, 2016
PubMed
12) Deguchi R, et al : Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. J Gastroenterol Hepatol, 27 : 888-892, 2012
PubMed
13) Ohtsu T, et al : The Ameliorating Effect of Lactobacillus gasseri OLL2716 on Functional Dyspepsia in Helicobacter pylori-Uninfected Individuals : A Randomized Controlled Study. Digestion, 96 : 92-102, 2017
PubMed
14) Suzuki T, et al : Yogurt Containing Lactobacillus gasseri Mitigates Aspirin-Induced Small Bowel Injuries : A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Digestion, 95 : 49-54, 2017
PubMed
15) Eguchi K, et al : Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055. Sci Rep, 9 : 4812, 2019
PubMed
16) Kadooka Y, et al : Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr, 64 : 636-643, 2010
 
17) Kadooka Y, et al : Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br J Nutr, 110 : 1696-1703, 2013
 
18) Ogawa A, et al : Lactobacillus gasseri SBT2055 suppresses fatty acid release through enlargement of fat emulsion size in vitro and promotes fecal fat excretion in healthy Japanese subjects. Lipids Health Dis, 14 : 20, 2015
PubMed
19) Ishida Y, et al : Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis : a double-blind, placebo-controlled study. J Dairy Sci, 88 : 527-533, 2005
 
20) Torii S, et al : Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum markers of atopic dermatitis in children. Int Arch Allergy Immunol, 154 : 236-245, 2011
PubMed
21) Yamamoto K, et al : Efficacy of prolonged ingestion of Lactobacillus acidophilus L-92 in adult patients with atopic dermatitis. J Dairy Sci, 99 : 5039-5046, 2016
PubMed
22) Inoue Y, et al : Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum cytokines of atopic dermatitis in Japanese adults : a double-blind, randomized, clinical trial. Int Arch Allergy Immunol, 165 : 247-254, 2014
PubMed
23) Nakata J, et al : Additive effect of Lactobacillus acidophilus L-92 on children with atopic dermatitis concomitant with food allergy. Asia Pac Allergy, 9 : e18, 2019
 
24) Yamada N, et al : Lactobacillus gasseri PA-3 Uses the Purines IMP, Inosine and Hypoxanthine and Reduces their Absorption in Rats. Microorganisms, 5 : doi : 10.3390/microorganisms5010010, 2017
 
25) Yamada N, et al : Evaluation of purine utilization by Lactobacillus gasseri strains with potential to decrease the absorption of food-derived purines in the human intestine. Nucleosides Nucleotides Nucleic Acids, 35 : 670-676, 2016
PubMed
26) Yamanaka H, et al : Hypouricaemic effects of yoghurt containing Lactobacillus gasseri PA-3 in patients with hyperuricaemia and/or gout : A randomised, double-blind, placebo-controlled study. Mod Rheumatol, 29 : 146-150, 2019
PubMed
27) Capurso L : Thirty Years of Lactobacillus rhamnosus GG : A Review. J Clin Gastroenterol, 53 Suppl 1 : S1-S41, 2019
PubMed
28) Szajewska H, et al : Systematic review with meta-analysis : Lactobacillus rhamnosus GG for treating acute gastroenteritis in children - a 2019 update. Aliment Pharmacol Ther, 49 : 1376-1384, 2019
PubMed
29) Li YT, et al : Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea : A systematic review with meta-analysis. World J Gastroenterol, 25 : 4999-5016, 2019
PubMed
30) Yonekura S, et al : Effects of daily intake of Lactobacillus paracasei strain KW3110 on Japanese cedar pollinosis. Allergy Asthma Proc, 30 : 397-405, 2009
PubMed
31) Morita Y, et al : Effect of Heat-Killed Lactobacillus paracasei KW3110 Ingestion on Ocular Disorders Caused by Visual Display Terminal (VDT) Loads : A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study. Nutrients, 10 : doi : 10.3390/nu10081058, 2018
 
32) Kotani Y, et al : Oral intake of Lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly : A randomized, placebo-controlled, double-blind trial. Immun Ageing, 7 : 11, 2010
PubMed
33) Shinkai S, et al : Immunoprotective effects of oral intake of heat-killed Lactobacillus pentosus strain b240 in elderly adults : a randomised, double-blind, placebo-controlled trial. Br J Nutr, 109 : 1856-1865, 2013
PubMed
34) Sugimura T, et al : Effects of oral intake of plasmacytoid dendritic cells-stimulative lactic acid bacterial strain on pathogenesis of influenza-like illness and immunological response to influenza virus. Br J Nutr, 114 : 727-733, 2015
PubMed
35) Suez J, et al : Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT. Cell, 174 : 1406-1423.e16, 2018
 
36) Murooka Y & Yamshita M : Traditional healthful fermented products of Japan. J Ind Microbiol Biotechnol, 35 : 791-798, 2008
PubMed
37) Fuke N, et al : Lactobacillus brevis KB290 With Vitamin A Ameliorates Murine Intestinal Inflammation Associated With the Increase of CD11c+ Macrophage/CD103- Dendritic Cell Ratio. Inflamm Bowel Dis, 24 : 317-331, 2018
PubMed
38) Fuke N, et al : Effect of combined consumption of Lactobacillus brevis KB290 and β-carotene on minor diarrhoea-predominant irritable bowel syndrome-like symptoms in healthy subjects : a randomised, double-blind, placebo-controlled, parallel-group trial. Int J Food Sci Nutr, 68 : 973-986, 2017
 
P.285 掲載の参考文献
1) Takagi T, et al : Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. J Gastroenterol, 54 : 53-63, 2019
PubMed
2) Kobayashi Y, et al : Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints : a randomised, double-blind, placebo-controlled trial. Benef Microbes, 10 : 511-520, 2019
PubMed
3) Primec M, et al : Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-α and short-chain fatty acids. Clin Nutr, 38 : 1373-1381, 2019
 
4) Matsuoka K, et al : Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis. Dig Dis Sci, 63 : 1910-1919, 2018
PubMed
5) Oki K, et al : Long-term colonization exceeding six years from early infancy of Bifidobacterium longum subsp. longum in human gut. BMC Microbiol, 18 : 209, 2018
PubMed
6) Underwood MA, et al : Bifidobacterium longum subspecies infantis : champion colonizer of the infant gut. Pediatr Res, 77 : 229-235, 2015
PubMed
7) Tamaki H, et al : Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis : A randomized, double-blinded, placebo-controlled multicenter trial. Dig Endosc, 28 : 67-74, 2016
PubMed
8) Lau AS, et al : Bifidobacterium longum BB536 alleviated upper respiratory illnesses and modulated gut microbiota profiles in Malaysian pre-school children. Benef Microbes, 9 : 61-70, 2018
PubMed
9) Pinto-Sanchez MI, et al : Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity : A Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology, 153 : 448-459.e8, 2017
 
10) Andresen V, et al : Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome : a multicentre, randomised, double-blind, placebo-controlled clinical trial. Lancet Gastroenterol Hepatol, 5 : 658-666, 2020
PubMed
P.286 掲載の参考文献
1) Sun YY, et al : The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome : a randomized, double-blind, placebo-controlled trial. Sci Rep, 8 : 2964, 2018
PubMed
P.296 掲載の参考文献
1) Huang R, et al : Probiotics for the Treatment of Atopic Dermatitis in Children : A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Cell Infect Microbiol, 7 : 392, 2017
PubMed
2) 消費者庁 : 機能性表示食品における軽症者データの取扱いに関する調査・検討事業 報告書, 2019 https://www.caa.go.jp/policies/policy/food_labeling/foods_with_function_claims/pdf/information_research_2018_190326_0001.pdf
 
3) Tan-Lim CSC, et al : Comparative effectiveness of probiotic strains for the treatment of pediatric atopic dermatitis : A systematic review and network meta-analysis. Pediatr Allergy Immunol : doi : 10.1111/pai.13305, 2020
 
4) King S, et al : Does probiotic consumption reduce antibiotic utilization for common acute infections? A systematic review and meta-analysis. Eur J Public Health, 29 : 494-499, 2019
PubMed
5) Sugimura T, et al : Effects of oral intake of plasmacytoid dendritic cells-stimulative lactic acid bacterial strain on pathogenesis of influenza-like illness and immunological response to influenza virus. Br J Nutr, 114 : 727-733, 2015
PubMed
6) Lei WT, et al : Effect of Probiotics and Prebiotics on Immune Response to Influenza Vaccination in Adults : A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 9 : doi : 10.3390/nu9111175, 2017
 
7) Takimoto T, et al : Effect of Bacillus subtilis C-3102 on bone mineral density in healthy postmenopausal Japanese women : a randomized, placebo-controlled, double-blind clinical trial. Biosci Microbiota Food Health, 37 : 87-96, 2018
 
P.304 掲載の参考文献
1) Lopez-Siles M, et al : Faecalibacterium prausnitzii : from microbiology to diagnostics and prognostics. ISME J, 11 : 841-852, 2017
PubMed
2) Ferreira-Halder CV, et al : Action and function of Faecalibacterium prausnitzii in health and disease. Best Pract Res Clin Gastroenterol, 31 : 643-648, 2017
PubMed
3) Quevrain E, et al : Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut, 65 : 415-425, 2016
PubMed
4) Verhoog S, et al : Dietary Factors and Modulation of Bacteria Strains of Akkermansia muciniphila and Faecalibacterium prausnitzii : A Systematic Review. Nutrients, 11 : doi : 10.3390/nu11071565, 2019
 
5) Belzer C & de Vos WM : Microbes inside--from diversity to function : the case of Akkermansia. ISME J, 6 : 1449-1458, 2012
PubMed
6) Zhou K : Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies. J Funct Foods, 33 : 194-201, 2017
PubMed
7) Tilg H & Moschen AR : Microbiota and diabetes : an evolving relationship. Gut, 63 : 1513-1521, 2014
PubMed
8) Everard A, et al : Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A, 110 : 9066-9071, 2013
PubMed
9) Shin NR, et al : An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut, 63 : 727-735, 2014
PubMed
10) Plovier H, et al : A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med, 23 : 107-113, 2017
PubMed
11) Ottman N, et al : Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS One, 12 : e0173004, 2017
PubMed
12) Cani PD & de Vos WM : Next-Generation Beneficial Microbes : The Case of Akkermansia muciniphila. Front Microbiol, 8 : 1765, 2017
PubMed
13) Roopchand DE, et al : Dietary Polyphenols Promote Growth of the Gut Bacterium Akkermansia muciniphila and Attenuate High-Fat Diet-Induced Metabolic Syndrome. Diabetes, 64 : 2847-2858, 2015
PubMed
14) Reunanen J, et al : Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer. Appl Environ Microbiol, 81 : 3655-3662, 2015
PubMed
15) Anhe FF & Marette A : A microbial protein that alleviates metabolic syndrome. Nat Med, 23 : 11-12, 2017
PubMed
16) Masumoto S, et al : Non-absorbable apple procyanidins prevent obesity associated with gut microbial and metabolomic changes. Sci Rep, 6 : 31208, 2016
PubMed
17) Gotoh A, et al : Use of Gifu Anaerobic Medium for culturing 32 dominant species of human gut microbes and its evaluation based on short-chain fatty acids fermentation profiles. Biosci Biotechnol Biochem, 81 : 2009-2017, 2017
PubMed
18) La Rosa SL, et al : The human gut Firmicute Roseburia intestinalis is a primary degrader of dietary β-mannans. Nat Commun, 10 : 905, 2019
 
19) Kasahara K, et al : Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model. Nat Microbiol, 3 : 1461-1471, 2018
 
20) Patterson AM, et al : Human Gut Symbiont Roseburia hominis Promotes and Regulates Innate Immunity. Front Immunol, 8 : 1166, 2017
PubMed
21) Khmaladze I, et al : Lactobacillus reuteri DSM 17938-A comparative study on the effect of probiotics and lysates on human skin. Exp Dermatol, 28 : 822-828, 2019
PubMed
22) Nilsson AG, et al : Lactobacillus reuteri reduces bone loss in older women with low bone mineral density : a randomized, placebo-controlled, double-blind, clinical trial. J Intern Med, 284 : 307-317, 2018
PubMed
23) Dore MP, et al : Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera(R) or Lactobacillus reuteri for treatment naive or for retreatment of Helicobacter pylori. Two randomized pilot studies. Helicobacter, 24 : e12659, 2019
 
24) Tenorio-Jimenez C, et al : Lactobacillus reuteri V3401 Reduces Inflammatory Biomarkers and Modifies the Gastrointestinal Microbiome in Adults with Metabolic Syndrome : The PROSIR Study. Nutrients, 11 : doi : 10.3390/nu11081761, 2019
 
25) Ojetti V, et al : The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation : a randomized, double-blind, placebo-controlled trial. J Gastrointestin Liver Dis, 23 : 387-391, 2014
 
26) Wegner A, et al : The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial. Clin Res Hepatol Gastroenterol, 42 : 494-500, 2018
PubMed
27) Riezzo G, et al : Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938 : improvement in symptoms and bowel habit in functional constipation. Benef Microbes, 9 : 51-60, 2018
PubMed
28) Kubota M, et al : Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation : A Double-Blind and Randomized Clinical Trial. Nutrients, 12 : doi : 10.3390/nu12010225, 2020
 
29) Riezzo G, et al : Effects of long-term administration of Lactobacillus reuteri DSM-17938 on circulating levels of 5-HT and BDNF in adults with functional constipation. Benef Microbes, 10 : 137-147, 2019
PubMed
30) Ritchie ML & Romanuk TN : A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One, 7 : e34938, 2012
PubMed
31) Nishiyama K, et al : A Double-Blind Controlled Study to Evaluate the Effects of Yogurt Enriched with Lactococcus lactis 11/19-B1 and Bif idobacterium lactis on Serum Low-Density Lipoprotein Level and Antigen-Specific Interferon-γ Releasing Ability. Nutrients, 10 : doi : 10.3390/nu10111778, 2018
 
32) Yeun Y & Lee J : Effect of a double-coated probiotic formulation on functional constipation in the elderly : a randomized, double blind, controlled study. Arch Pharm Res, 38 : 1345-1350, 2015
PubMed
33) Airaksinen K, et al : The effect of a probiotic blend on gastrointestinal symptoms in constipated patients : a double blind, randomised, placebo controlled 2-week trial. Benef Microbes, 10 : 617-627, 2019
PubMed
34) Dennis-Wall JC, et al : Probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies : a double-blind, placebo-controlled, randomized trial. Am J Clin Nutr, 105 : 758-767, 2017
PubMed
35) Borges NA, et al : Probiotic Supplementation in Chronic Kidney Disease : A Double-blind, Randomized, Placebo-controlled Trial. J Ren Nutr, 28 : 28-36, 2018
 
36) Zaharuddin L, et al : A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer. BMC Gastroenterol, 19 : 131, 2019
 
P.313 掲載の参考文献
1) Bartlett JG : Clinical practice. Antibiotic-associated diarrhea. N Engl J Med, 346 : 334-339, 2002
PubMed
2) van Nood E, et al : Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med, 368 : 407-415, 2013
 
3) Quraishi MN, et al : Systematic review with meta-analysis : the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther, 46 : 479-493, 2017
PubMed
4) Costello SP, et al : Systematic review with meta-analysis : faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment Pharmacol Ther, 46 : 213-224, 2017
PubMed
5) Ishikawa D, et al : Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis. Inflamm Bowel Dis, 23 : 116-125, 2017
PubMed
6) Ishikawa D, et al : The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics. Inflamm Bowel Dis, 24 : 2590-2598, 2018
PubMed
7) Okahara K, et al : Matching between Donors and Ulcerative Colitis Patients Is Important for Long-Term Maintenance after Fecal Microbiota Transplantation. J Clin Med, 9 : doi : 10.3390/jcm9061650, 2020
 
8) Tian H, et al : Fecal microbiota transplantation in patients with slow-transit constipation : A randomized, clinical trial. PLoS One, 12 : e0171308, 2017
PubMed
9) Myneedu K, et al : Fecal microbiota transplantation in irritable bowel syndrome : A systematic review and meta-analysis. United European Gastroenterol J, 7 : 1033-1041, 2019
PubMed
10) Xu D, et al : Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome : A Systematic Review and Meta-Analysis. Am J Gastroenterol, 114 : 1043-1050, 2019
PubMed
11) Ianiro G, et al : Systematic review with meta-analysis : efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther, 50 : 240-248, 2019
PubMed
12) 「機能性消化管疾患診療ガイドライン 2020 改訂第2版 過敏性腸症候群 (IBS) 」 (日本消化器病学会/編), 南江堂, 2020
 
13) El-Salhy M, et al : Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut, 69 : 859-867, 2020
 
14) Mizuno S, et al : Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome. Digestion, 96 : 29-38, 2017
PubMed
15) Kakihana K, et al : Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. Blood, 128 : 2083-2088, 2016
PubMed
16) Spindelboeck W, et al : Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease. Haematologica, 102 : e210-e213, 2017
PubMed
17) Qi X, et al : Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation : A Pilot Study. Front Immunol, 9 : 2195, 2018
PubMed
18) Moayyedi P, et al : Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology, 149 : 102-109.e6, 2015
 
19) DeFilipp Z, et al : Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. N Engl J Med, 381 : 2043-2050, 2019
PubMed
P.325 掲載の参考文献
1) So D, et al : Dietary fiber intervention on gut microbiota composition in healthy adults : a systematic review and meta-analysis. Am J Clin Nutr, 107 : 965-983, 2018
PubMed
2) 厚生労働省 : 日本人の食事摂取基準 (2020年版) https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/syokuji_kijyun.html
 
3) Higashimura Y, et al : Oligosaccharides from agar inhibit murine intestinal inflammation through the induction of heme oxygenase-1 expression. J Gastroenterol, 48 : 897-909, 2013
PubMed
4) Higashimura Y, et al : Preventive effect of agaro-oligosaccharides on non-steroidal anti-inflammatory drug-induced small intestinal injury in mice. J Gastroenterol Hepatol, 29 : 310-317, 2014
PubMed
5) Higashimura Y, et al : Agaro-Oligosaccharides Regulate Gut Microbiota and Adipose Tissue Accumulation in Mice. J Nutr Sci Vitaminol (Tokyo), 63 : 269-276, 2017
PubMed
6) Higashimura Y, et al : Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice. Am J Physiol Gastrointest Liver Physiol, 310 : G367-G375, 2016
PubMed
7) 厚生労働省 : 「栄養表示基準における栄養成分等の分析方法等について」の一部改正について (平成15年2月17日) (食新発第0217002号) https://www.mhlw.go.jp/web/t_doc?dataId=00ta5112&dataType=1&pageNo=1
 
8) Yasukawa Z, et al : Effect of Repeated Consumption of Partially Hydrolyzed Guar Gum on Fecal Characteristics and Gut Microbiota : A Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Clinical Trial. Nutrients, 11 : doi : 10.3390/nu11092170, 2019
 
P.328 掲載の参考文献
1) Duan Y, et al : Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature, 575 : 505-511, 2019
PubMed
2) Fujimoto K, et al : Metagenome Data on Intestinal Phage-Bacteria Associations Aids the Development of Phage Therapy against Pathobionts. Cell Host Microbe, 28 : 380-389.e9, 2020
 

書評

最近チェックした商品履歴

Loading...